Publicaciones en colaboración con investigadores/as de Hospital de Cabueñes (60)

2024

  1. Cyclosporin A as an Add-On Therapy to a Corticosteroid-Based Background Treatment in Patients with COVID-19: A Multicenter, Randomized Clinical Trial

    Journal of Clinical Medicine, Vol. 13, Núm. 17

  2. Exposure to different occupational chemicals and clinical phenotype of a cohort of patients with systemic sclerosis

    Autoimmunity Reviews

  3. Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study

    The Lancet Diabetes and Endocrinology, Vol. 12, Núm. 9, pp. 643-652

  4. Prognostic Value of D-dimer to Lymphocyte Ratio (DLR) in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients: A Validation Study in a National Cohort

    Viruses, Vol. 16, Núm. 3

2023

  1. Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial

    JAMA Network Open, Vol. 6, Núm. 4, pp. E237243

  2. Impact of days elapsed from the onset of symptoms to hospitalization in COVID-19 in-hospital mortality: Time matters

    Revista Clinica Espanola, Vol. 223, Núm. 5, pp. 281-297

2022

  1. Anti–Polymyositis/Scl Antibodies in Systemic Sclerosis Clinical Associations in a Multicentric Spanish Cohort and Review of the Literature

    Journal of Clinical Rheumatology, Vol. 28, Núm. 1, pp. E180-E188

  2. Approximation to the cost of occupational diseases treated in seven hospitals in Spain

    Gaceta Sanitaria, Vol. 36, Núm. 3, pp. 253-256

  3. Derivation and validation of a risk score for admission to the Intensive Care Unit in patients with COVID-19

    Revista Clinica Espanola, Vol. 222, Núm. 1, pp. 1-12

  4. Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry

    Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 761-775

  5. Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry

    International Journal of Infectious Diseases, Vol. 116, pp. 51-58

2021

  1. Clinical Characteristics and Risk Factors of Respiratory Failure in a Cohort of Young Patients Requiring Hospital Admission with SARS-CoV2 Infection in Spain: Results of the Multicenter SEMI-COVID-19 Registry

    Journal of General Internal Medicine, Vol. 36, Núm. 10, pp. 3080-3087

  2. Clinical characterization and outcomes of 85 patients with neurosarcoidosis

    Scientific Reports, Vol. 11, Núm. 1

  3. Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients

    Joint Bone Spine, Vol. 88, Núm. 6

  4. Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))

    Autoimmunity Reviews

  5. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

  6. Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience

    Journal of Clinical Lipidology, Vol. 15, Núm. 4, pp. 584-592

  7. Evolution of the use of corticosteroids for the treatment of hospitalised COVID-19 patients in Spain between March and November 2020: SEMI-COVID national registry

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  8. Gender-based differences by age range in patients hospitalized with covid-19: A spanish observational cohort study

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-21

  9. Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry

    PLoS ONE, Vol. 16, Núm. 2 February